U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C28H27NO4S.ClH
Molecular Weight 510.044
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of RALOXIFENE HYDROCHLORIDE

SMILES

Cl.OC1=CC=C(C=C1)C2=C(C(=O)C3=CC=C(OCCN4CCCCC4)C=C3)C5=C(S2)C=C(O)C=C5

InChI

InChIKey=BKXVVCILCIUCLG-UHFFFAOYSA-N
InChI=1S/C28H27NO4S.ClH/c30-21-8-4-20(5-9-21)28-26(24-13-10-22(31)18-25(24)34-28)27(32)19-6-11-23(12-7-19)33-17-16-29-14-2-1-3-15-29;/h4-13,18,30-31H,1-3,14-17H2;1H

HIDE SMILES / InChI

Approval Year

Unknown
86413
Name Type Language
RALOXIFENE HYDROCHLORIDE
EMA EPAR   EP   JAN   MART.   MI   ORANGE BOOK   USAN   USP   USP-RS   VANDF   WHO-DD  
USAN  
Official Name English
RALOXIFENE HYDROCHLORIDE [JAN]
Common Name English
NSC-706725
Code English
6-HYDROXY-2-(P-HYDROXYPHENYL)BENZO(.BETA.)THIEN-3-YL-P-(2-PIPERIDINOETHOXY)PHENYL KETONE, HYDROCHLORIDE
Common Name English
RALOXIFENE HYDROCHLORIDE [USP MONOGRAPH]
Common Name English
RALOXIFENE HYDROCHLORIDE [EP MONOGRAPH]
Common Name English
METHANONE, (6-HYDROXY-2-(4-HYDROXYPHENYL)BENZO(.BETA.)THIEN-3-YL)(4-(2-(1-PIPERIDINYL)ETHOXY)PHENYL)-, HYDROCHLORIDE
Common Name English
RALOXIFENE HCL
Common Name English
RALOXIFENE HYDROCHLORIDE [USAN]
Common Name English
RALOXIFENE HYDROCHLORIDE [VANDF]
Common Name English
Raloxifene hydrochloride [WHO-DD]
Common Name English
RALOXIFENE HYDROCHLORIDE [MI]
Common Name English
RALOXIFENE TEVA
Brand Name English
RALOXIFENE HYDROCHLORIDE [MART.]
Common Name English
OPTRUMA
Brand Name English
LY156758
Code English
EVISTA
Common Name English
LY-156758
Code English
RALOXIFENE HYDROCHLORIDE [EMA EPAR]
Common Name English
RALOXIFENE HYDROCHLORIDE [ORANGE BOOK]
Common Name English
RALOXIFENE HYDROCHLORIDE [USP IMPURITY]
Common Name English
RALOXIFENE HYDROCHLORIDE [USP-RS]
Common Name English
Classification Tree Code System Code
EMA ASSESSMENT REPORTS EVISTA (AUTHORIZED: OSTEOPOROSIS, POSTMENOPAUSAL)
Created by admin on Fri Dec 15 15:46:24 UTC 2023 , Edited by admin on Fri Dec 15 15:46:24 UTC 2023
EMA ASSESSMENT REPORTS OPTRUMA (AUTHORIZED: OSTEOPOROSIS, POSTMENOPAUSAL)
Created by admin on Fri Dec 15 15:46:24 UTC 2023 , Edited by admin on Fri Dec 15 15:46:24 UTC 2023
FDA ORPHAN DRUG 309910
Created by admin on Fri Dec 15 15:46:24 UTC 2023 , Edited by admin on Fri Dec 15 15:46:24 UTC 2023
EU-Orphan Drug EU/3/10/730
Created by admin on Fri Dec 15 15:46:24 UTC 2023 , Edited by admin on Fri Dec 15 15:46:24 UTC 2023
EMA ASSESSMENT REPORTS RALOXIFENE TEVA (AUTHORIZED: OSTEOPOROSIS, POSTMENOPAUSAL)
Created by admin on Fri Dec 15 15:46:24 UTC 2023 , Edited by admin on Fri Dec 15 15:46:24 UTC 2023
NCI_THESAURUS C1821
Created by admin on Fri Dec 15 15:46:24 UTC 2023 , Edited by admin on Fri Dec 15 15:46:24 UTC 2023
Code System Code Type Description
ChEMBL
CHEMBL81
Created by admin on Fri Dec 15 15:46:24 UTC 2023 , Edited by admin on Fri Dec 15 15:46:24 UTC 2023
PRIMARY
PUBCHEM
54900
Created by admin on Fri Dec 15 15:46:24 UTC 2023 , Edited by admin on Fri Dec 15 15:46:24 UTC 2023
PRIMARY
NSC
706725
Created by admin on Fri Dec 15 15:46:24 UTC 2023 , Edited by admin on Fri Dec 15 15:46:24 UTC 2023
PRIMARY
CAS
82640-04-8
Created by admin on Fri Dec 15 15:46:24 UTC 2023 , Edited by admin on Fri Dec 15 15:46:24 UTC 2023
PRIMARY
USAN
U-8
Created by admin on Fri Dec 15 15:46:24 UTC 2023 , Edited by admin on Fri Dec 15 15:46:24 UTC 2023
PRIMARY
DRUG BANK
DBSALT000272
Created by admin on Fri Dec 15 15:46:24 UTC 2023 , Edited by admin on Fri Dec 15 15:46:24 UTC 2023
PRIMARY
RS_ITEM_NUM
1598201
Created by admin on Fri Dec 15 15:46:24 UTC 2023 , Edited by admin on Fri Dec 15 15:46:24 UTC 2023
PRIMARY
EPA CompTox
DTXSID1034181
Created by admin on Fri Dec 15 15:46:24 UTC 2023 , Edited by admin on Fri Dec 15 15:46:24 UTC 2023
PRIMARY
EVMPD
SUB12568MIG
Created by admin on Fri Dec 15 15:46:24 UTC 2023 , Edited by admin on Fri Dec 15 15:46:24 UTC 2023
PRIMARY
SMS_ID
100000091054
Created by admin on Fri Dec 15 15:46:24 UTC 2023 , Edited by admin on Fri Dec 15 15:46:24 UTC 2023
PRIMARY
RXCUI
166551
Created by admin on Fri Dec 15 15:46:24 UTC 2023 , Edited by admin on Fri Dec 15 15:46:24 UTC 2023
PRIMARY RxNorm
MERCK INDEX
m9485
Created by admin on Fri Dec 15 15:46:24 UTC 2023 , Edited by admin on Fri Dec 15 15:46:24 UTC 2023
PRIMARY Merck Index
NCI_THESAURUS
C1762
Created by admin on Fri Dec 15 15:46:24 UTC 2023 , Edited by admin on Fri Dec 15 15:46:24 UTC 2023
PRIMARY
CHEBI
50740
Created by admin on Fri Dec 15 15:46:24 UTC 2023 , Edited by admin on Fri Dec 15 15:46:24 UTC 2023
PRIMARY
DAILYMED
4F86W47BR6
Created by admin on Fri Dec 15 15:46:24 UTC 2023 , Edited by admin on Fri Dec 15 15:46:24 UTC 2023
PRIMARY
FDA UNII
4F86W47BR6
Created by admin on Fri Dec 15 15:46:24 UTC 2023 , Edited by admin on Fri Dec 15 15:46:24 UTC 2023
PRIMARY
ACTIVE MOIETY
Structure of RALOXIFENE
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966